Cherry Hill, NJ, United States of America

Karuppiah Muthumani

This inventor holds 30 USPTO granted patents and 11 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Vaccine Development. Top assignees: University of Pennsylvania, Inovio Pharmaceuticals, Inc., The Trustees of the Universtiy of Pennsylvania. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karuppiah Muthumani. Retrieved from https://idiyas.com/inventor/karuppiah-muthumani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 11)

% Patents Active = 90.0

CIPO Patents = 6 (Patent Applications = 23)

EPO Patents = 7 (Patent Applications = 21)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 31(Granted Patents)

Company Filing History:

28 out of 2,659

University of Pennsylvania

patents

14 out of 93

Inovio Pharmaceuticals, Inc.

patents

1 out of 3

The Trustees of the Universtiy of Pennsylvania

Vgx Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

Areas of Expertise:

Vaccine

Immunotherapy

FMDV

MERS-CoV

Antibody Constructs

Biomolecular Adjuvants

Synthetic Antibody

Chikungunya

Nucleic Acid Constructs

Targeted Particles

Cancer Vaccines

Cell Death Induction

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12049479 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom (2024-07-30),

2. 11925685 - DNA antibody constructs encoding anti-ZIKV envelope antibodies (2024-03-12),

3. 11801298 - MERS-CoV vaccine (2023-10-31),

4. 11419925 - Cancer vaccines and methods of treatment using the same (2022-08-23),

5. 11278619 - DNA antibody constructs and method of using same (2022-03-22),

6. 11208470 - DNA antibody constructs and method of using same (2021-12-28),

7. 11179458 - Immunogenicity of an optimized synthetic consensus DNA vaccine for porcine epidemic diarrhea virus (2021-11-23),

8. 11135284 - MERS-CoV vaccine (2021-10-05),

9. 11124545 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom (2021-09-21),

10. 11116838 - Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy (2021-09-14),

11. 11027011 - Vaccines with biomolecular adjuvants (2021-06-08),

12. 10835595 - PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy (2020-11-17),

13. 10548971 - MERS-CoV vaccine (2020-02-04),

14. 10294278 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom (2019-05-21),

15. 10226528 - Vaccines with biomolecular adjuvants (2019-03-12),

Title: The Innovative Journey of Karuppiah Muthumani

Introduction: Karuppiah Muthumani, a talented inventor based in Cherry Hill, NJ, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Karuppiah Muthumani holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Muthumani has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Karuppiah Muthumani has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and create impactful solutions.

Conclusion: Karuppiah Muthumani's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.